Cite
HARVARD Citation
Shitara, K. et al. (2017). Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial. Lancet gastroenterology and hepatology. pp. 277-287. [Online].